Consolidation of image interpretation assistance into one package can minimize costs and open the market to radiology providers who cannot afford current offerings, scientists write in Radiology.
IRs can play a key role in kidney care using a novel, nonsurgical approach that deploys catheters and imaging guidance to create a fistula in the arm for dialysis access.
Robert C. O’Laughlin, MD, and attorneys first took Radiation Therapy Services and its physicians to court in late 2016, citing qui tam provisions of the False Claims Act.
Even before the onset of COVID-19, data suggested that rads’ after-hours workloads had doubled in proportion to the increase in emergency department visits in the years leading up to 2020.
The federal payment program first proposed this 2.5%, across-the-board cut for physician services in July, exempting most time-based healthcare offerings.
The findings come amid reports of a “major” workforce shortage in pediatric radiology, driven by decreased trainee interest in related fellowships, rising clinical volumes and a competitive job market.
Five years after Congress passed the landmark law, shortcomings persist, which are potentially hampering patients and physicians, House leaders contend.
“Clinicians should carefully weigh the additional resource utilization against the potential benefit," Yale University emergency medicine experts write in JACR.
Jonathan R. Medverd, MD, emphasized the valuable role such professionals play on physician-led teams, but emphasized they do not have the skills to interpret medical images.
Join three imaging experts on Aug. 26 to learn more about imaging storage-as-a-service in which you pay once to save and manage a study forever, with costs as low as 2.5 cents per exam.
Even before the onset of COVID-19, data suggested that rads’ after-hours workloads had doubled in proportion to the increase in emergency department visits in the years leading up to 2020.
“The explanation here is simple. Ultrasound gives you more information, and more concrete information, about what’s going on,” authors of a new JAMA study say.
“FDA clearance comes at the perfect time, with guidelines being adopted clinically for cardiac CT and with positive reimbursement driving procedure growth," says Jean-Luc Procaccini, CEO, molecular imaging and CT.
